Global
About
Development milestones Mission&Vision Founder Research Achievement
Technology Platforms
Single domain antibody Five core technology platforms
Pipeline
Business cooperation
Product Out-Licensing Co-Development
Career development
Our Story Social Recruitment
News
Company News Media
Contact Us
Company Address Online Message
×
Our Story

Share the latest information

Our Story
News
Company News
Media
2024-12-19
Novamab has been listed on the 2024 Cyzone 100 Future Unicorn List
More
2020-09-17
Novamab won the recognition of high-tech enterprises in Shanghai!
More
2019-11-22
The joint research results of Novamab and Peking University Cancer Hospital in nuclear medicine were published online in the international journal BIOCONJUGATE CHEMISTRY
More
2019-10-16
Publication of research and development results of industrialized new PD-1 nanoantibody drug expressed by Pichia pastoris
More
2019-10-10
Report on the 29th ERS (European Respiratory Society Annual Conference) Conference of Loki Biology
More
2019-07-27
Don't forget your original intention and move forward courageously -- and Loqi 2019 Mid-Year Summary and Commendation Conference
More
2019-04-11
LQ036, the world's first inhaled nano-antibody drug for the treatment of moderate and severe asthma, has completed the administration of the first patient in China's clinical phase I!
More
2018-10-31
Novamab won the winner of the 2018 "Entrepreneurship in Shanghai" International Innovation and Entrepreneurship Competition
More
总计 47 12345